Article
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
Neurology - 8 Mar 2005
Linnebank M, Pels H, Kleczar N, Farmand S, Fliessbach K, Urbach H, Orlopp K, Klockgether T, Schmidt-Wolf I G H, Schlegel U
Abstract excerpt
Methotrexate (MTX) is a folate antagonist inhibiting nucleic acid and methionine synthesis. Methionine is necessary for CNS myelination. In 42 patients with primary CNS lymphoma (PCNSL) treated with a systemic and intraventricular high-dose MTX-based polychemotherapy, the presence of a risk haplotype defined by polymorphisms influencing methionine metabolism referred a relative risk for CNS white matter changes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
